1
|
Meyer M, Montel S, Colnat-Coulbois S, Frismand S, Llorca PM, Vidailhet P, Schwan R, Spitz E. Parkinson's Disease: Coping Strategies, Cognitive Restructuring and Deep Brain Stimulation. J Geriatr Psychiatry Neurol 2024:8919887241248831. [PMID: 38801752 DOI: 10.1177/08919887241248831] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/29/2024]
Abstract
OBJECTIVE Less is known concerning the evolution of coping strategies before and after deep brain stimulation (DBS) in Parkinson's disease (PD) patients. METHODS In a randomized controlled trial, coping was measured with the neurological version of the CHIP (Coping with Health Injuries and Problem) and the BriefCOPE in PD patients before ( T1: DBS - 2 months) and after (T2: + 3 months, T3: + 6 months) DBS. Patients (N = 50, age 59 ± 5.7 years, disease duration 9.54 ± 3.7 years) were randomised in 3 groups: CRTG (preoperative psychological preparation with cognitive restructuring), PIG (preoperative non structured interviews), and CG (no psychological preparation). RESULTS Coping strategies are modulated by the time of evaluation. Some strategies are significantly more used preoperatively than postoperatively, as strategies about the research for information (CHIP: F = 16.14; P = .000; η2 = .095; BriefCOPE F = 5.71; P = .005; η2 = .066), emotional regulation (F = 3.29; P = .042; η2 = .029), and well-being searching (F = 4.59; P = .013; η2 = .043). Some other strategies appear more used post than preoperatively, as palliative coping (F = 5.57; P = .005; η2 = .064), humour (F = 3.35; P = .041; η2 = .0.35), and use of substance (F = 4.43; P = .015; η2 = .070). No other specific time, group or time per group interaction effect was found. CONCLUSION Coping strategies are crucial for PD patients to adapt to the evolution of their parkinsonian state. Their consideration should be more systematic in the neurosurgical process, particularly when neurological symptoms would remain after DBS. More insights are needed concerning the evolution of coping strategies through DBS and the impact of a preoperative psychotherapy over them in preoperative PD patients.
Collapse
Affiliation(s)
- Mylène Meyer
- Service de Neurologie, Hôpital Central, CHRU Nancy, Nancy, France
| | - Sébastien Montel
- Mission Hospital, Mission Viejo, CA, USA
- Université de Lorraine, UMR 1319 INSPIIRE, Équipe Psychologie de la Santé de Metz (EPSAM), Metz, France
| | - Sophie Colnat-Coulbois
- Département de Neurochirurgie, Hôpital Central, CHRU de Nancy, Nancy, France
- Université de Lorraine, Nancy, France
| | - Solène Frismand
- Service de Neurologie, Hôpital Central, CHRU Nancy, Nancy, France
| | | | | | - Raymund Schwan
- Université de Lorraine, Nancy, France
- Centre Psychothérapique de Nancy, Nancy, France
| | - Elisabeth Spitz
- Université de Lorraine, UMR 1319 INSPIIRE, Équipe Psychologie de la Santé de Metz (EPSAM), Metz, France
- Université de Lorraine, Nancy, France
| |
Collapse
|
2
|
Halimi L, Suehs CM, Marin G, Boissin C, Gamez AS, Vachier I, Molinari N, Bourdin A. Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study. ERJ Open Res 2021; 7:00617-2020. [PMID: 34435036 PMCID: PMC8381263 DOI: 10.1183/23120541.00617-2020] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2020] [Accepted: 03/27/2021] [Indexed: 11/05/2022] Open
Abstract
Objectives The role of health-related quality of life (HRQoL) and psychological variables in pulmonary arterial hypertension (PAH) progression remains poorly quantified. We aimed to investigate the relationship between disease progression in PAH patients and HRQoL and psychological characteristics. Methods A 3-year longitudinal cohort was initiated. Patients with stable PAH (groups I-IV ineligible for angioplasty/endarterectomy) were included (n=55). Standard clinical variables, including invasive haemodynamic parameters, were prospectively recorded. A battery of questionnaires was used to characterise the psychological status of patients upon study initiation, and HRQoL was quantified using the SF-36 Questionnaire every 3 months for 24 months, and then again at 36 months. Guideline-defined disease progression and progression-free survival were recorded for 36 months. Measurements and main results Psychological distress was highly prevalent at baseline. The Physical Component Summary (PCS) and the Mental Component Summary (MCS) of the HRQoL were poor (PCS=37.13±8.18; MCS=42.42±10.88) but stable over 3 years of follow-up. Among PCS subscales, Physical Functioning (PF) (p=0.012) was identified as being independently associated with disease progression (Cox survival model), along with mean pulmonary arterial pressure (p=0.003) and cardiac output (p=0.005). Depression was the unique independent psychological characteristic associated with PF (p=0.0001). Conclusions PAH patients have poor HRQoL. In addition to already known criteria related to disease severity, the HRQoL PF subscale is independently associated with disease progression in PAH. This may be explained by depression.
Collapse
Affiliation(s)
- Laurence Halimi
- Dept of Respiratory Diseases, Université de Montpellier, CHU Montpellier, Montpellier, France
| | - Carey M Suehs
- Dept of Respiratory Diseases, Université de Montpellier, CHU Montpellier, Montpellier, France.,Dept of Medical Information, Université de Montpellier, CHU Montpellier, Montpellier, France
| | - Gregory Marin
- Dept of Medical Information, Université de Montpellier, CHU Montpellier, Montpellier, France
| | - Clement Boissin
- Dept of Respiratory Diseases, Université de Montpellier, CHU Montpellier, Montpellier, France
| | - Anne-Sophie Gamez
- Dept of Respiratory Diseases, Université de Montpellier, CHU Montpellier, Montpellier, France
| | - Isabelle Vachier
- Dept of Respiratory Diseases, Université de Montpellier, CHU Montpellier, Montpellier, France
| | - Nicolas Molinari
- Dept of Medical Information, Université de Montpellier, CHU Montpellier, Montpellier, France.,IMAG, CNRS, Université de Montpellier, CHU Montpellier, Montpellier, France
| | - Arnaud Bourdin
- Dept of Respiratory Diseases, Université de Montpellier, CHU Montpellier, Montpellier, France.,PhyMedExp, Université de Montpellier, CNRS, INSERM 1046, CHU Montpellier, Montpellier, France
| |
Collapse
|
3
|
Impact of psychological factors on the health-related quality of life of patients treated for pulmonary arterial hypertension. J Psychosom Res 2018; 105:45-51. [PMID: 29332633 DOI: 10.1016/j.jpsychores.2017.12.003] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/05/2017] [Revised: 11/30/2017] [Accepted: 12/01/2017] [Indexed: 01/30/2023]
Abstract
OBJECTIVE Pulmonary arterial hypertension (PAH) is a rare and life-threatening disease well-marked by under diagnosis, delayed diagnosis and atypical treatments. Few data are available on the quality of life (QoL) and psychosocial characteristics of patients with PAH. Our aim is to describe the impact of psychological factors on the health-related quality of life (HRQoL) of treated PAH patients in a cross-sectional study. METHODS Consecutive patients presenting at our Competency Centre for PAH were recruited. The aetiology, New York Heart Association (NYHA) stage, haemodynamics, 6-min walk distance (6MWD), delta SPO2 (Pulse oximeter oxygen saturation; baseline lowest value during 6-min walk test (6MWT), current treatments and psychological history were recorded. HRQoL, anxiety, depression and coping strategies were explored using self-administered questionnaires (SF-36, HADS, STAI-Y, CHIP and WCC). RESULTS A total of 55 patients were included. The HRQoL of PAH patients was poor with altered results on several scales. Anxiety and depression were high and coping was focused on medical information strategies. Multivariate analysis indicated a positive relationship between 6MWD and the Physical Composite Score for QoL (p=0.004), as well as a negative relationship between delta SPO2 and the Mental Composite Score (p=0.02), irrespective of other known prognostic factors (such as haemodynamics at right heart catheterization). Depression and Trait-Anxiety were associated with a lower physical (p=0.001) and mental (p<0.001) QoL, respectively. CONCLUSIONS Psychological factors impact the HRQoL of treated patients. A longitudinal and qualitative study should refine these results. TRIAL REGISTRATION Clinical trial N°: NCT01380054.
Collapse
|
4
|
Gay MC, Bungener C, Thomas S, Vrignaud P, Thomas PW, Baker R, Montel S, Heinzlef O, Papeix C, Assouad R, Montreuil M. Anxiety, emotional processing and depression in people with multiple sclerosis. BMC Neurol 2017; 17:43. [PMID: 28231828 PMCID: PMC5324294 DOI: 10.1186/s12883-017-0803-8] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2016] [Accepted: 01/20/2017] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Despite the high comorbidity of anxiety and depression in people with multiple sclerosis (MS), little is known about their inter-relationships. Both involve emotional perturbations and the way in which emotions are processed is likely central to both. The aim of the current study was to explore relationships between the domains of mood, emotional processing and coping and to analyse how anxiety affects coping, emotional processing, emotional balance and depression in people with MS. METHODS A cross-sectional questionnaire study involving 189 people with MS with a confirmed diagnosis of MS recruited from three French hospitals. Study participants completed a battery of questionnaires encompassing the following domains: i. anxiety and depression (Hospital Anxiety and Depression Scale (HADS)); ii. emotional processing (Emotional Processing Scale (EPS-25)); iii. positive and negative emotions (Positive and Negative Emotionality Scale (EPN-31)); iv. alexithymia (Bermond-Vorst Alexithymia Questionnaire) and v. coping (Coping with Health Injuries and Problems-Neuro (CHIP-Neuro) questionnaire. Relationships between these domains were explored using path analysis. RESULTS Anxiety was a strong predictor of depression, in both a direct and indirect way, and our model explained 48% of the variance of depression. Gender and functional status (measured by the Expanded Disability Status Scale) played a modest role. Non-depressed people with MS reported high levels of negative emotions and low levels of positive emotions. Anxiety also had an indirect impact on depression via one of the subscales of the Emotional Processing Scale ("Unregulated Emotion") and via negative emotions (EPN-31). CONCLUSIONS This research confirms that anxiety is a vulnerability factor for depression via both direct and indirect pathways. Anxiety symptoms should therefore be assessed systematically and treated in order to lessen the likelihood of depression symptoms.
Collapse
Affiliation(s)
- Marie-Claire Gay
- Psychology Department, University of Paris West, Nanterre, France.
| | - Catherine Bungener
- Laboratory of Psychopathology, University of Paris Descartes, Paris, France.,Health Psychology, Université Paris Sorbonne Cité, Paris, France
| | - Sarah Thomas
- Clinical Research Unit, Faculty of Health and Social Sciences, Bournemouth University, Bournemouth, UK
| | - Pierre Vrignaud
- Psychology Department, University of Paris West, Nanterre, France
| | - Peter W Thomas
- Clinical Research Unit, Faculty of Health and Social Sciences, Bournemouth University, Bournemouth, UK
| | - Roger Baker
- Clinical Research Unit, Faculty of Health and Social Sciences, Bournemouth University, Bournemouth, UK
| | | | - Olivier Heinzlef
- Neurology Department, Hospital of Poissy-St-Germain en Laye, Paris, France
| | | | - Rana Assouad
- Neurology Department, GHPS Pitié Salpêtrière, Paris, France
| | | |
Collapse
|
5
|
Mosson M, Peter L, Montel S. [Impact of physical activity level on alexithymia and coping strategies in an over-40 multiple sclerosis population: a pilot study]. Rev Neurol (Paris) 2013; 170:19-25. [PMID: 24238784 DOI: 10.1016/j.neurol.2013.04.009] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2012] [Revised: 04/02/2013] [Accepted: 04/17/2013] [Indexed: 11/28/2022]
Abstract
INTRODUCTION The aim of this study was to evaluate the impact of physical activity on alexithymia and coping strategies among people with multiple sclerosis aged over 40. The hypotheses were that physical activity should have a protective effect on alexithymia, and more particularly, on "emotional identification" and could influence coping strategies because it can be considered as a distractive coping strategy. METHODS Thirty-seven patients aged 40 years or older were asked to complete a form including an identification sheet and standardized questionnaires: the Bermond-Vorst Alexithymia Questionnaire (version B), the Coping with Health Injuries and Problem Questionnaire, the Fatigue Impact Scale, and the Hospital Anxiety and Depression Scale. RESULTS The participants with a high or moderate level of physical activity used "information research" as a coping strategy better than those who had a lower level of physical activity. They also analyzed their emotions better. The results revealed an association between these variables and anxiety, depression and fatigue. DISCUSSION This study provides insight for future research about the impact of physical activity on multiple sclerosis.
Collapse
Affiliation(s)
- M Mosson
- Département de psychologie, université de Lorraine, site de Metz, Ile-du-Saulcy, BP 30309, 57006 Metz cedex 1, France.
| | - L Peter
- Département de psychologie, université de Lorraine, site de Metz, Ile-du-Saulcy, BP 30309, 57006 Metz cedex 1, France; Laboratoire de psychologie de la santé de Metz, UFR sciences humaines et arts, Ile-du-Saulcy, BP 30309, 57006 Metz cedex 1, France
| | - S Montel
- UFR de psychologie, université de Paris 8, Vincennes-Saint-Denis, 2, rue de la Liberté, 93526 Saint-Denis cedex, France; EA 2027, laboratoire de psychopathologie et de neuropsychologie, université Paris 8, UFR psychologie, 2, rue de la Liberté, 93526 Saint-Denis cedex, France
| |
Collapse
|
6
|
Mylène M, Sébastien M, Sophie CC, Jérôme L, Jevita P, Pierre V, Nicolaie G, Hervé V, Gérard B, Elisabeth S, Raymund S. Neurosurgery in Parkinson's disease: Social adjustment, quality of life and coping strategies. Neural Regen Res 2013; 8:2856-67. [PMID: 25206607 PMCID: PMC4146014 DOI: 10.3969/j.issn.1673-5374.2013.30.008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2013] [Accepted: 05/18/2013] [Indexed: 12/02/2022] Open
Abstract
Subthalamic nucleus deep brain stimulation has become a standard neurosurgical therapy for advanced Parkinson's disease. Subthalamic nucleus deep brain stimulation can dramatically improve the motor symptoms of carefully selected patients with this disease. Surprisingly, some specific dimensions of quality of life, “psychological” aspects and social adjustment do not always improve, and they could sometimes be even worse. Patients and their families should fully understand that subthalamic nucleus deep brain stimulation can alter the motor status and time is needed to readapt to their new postoperative state and lifestyles. This paper reviews the literatures regarding effects of bilateral subthalamic nucleus deep brain stimulation on social adjustment, quality of life and coping strategies in patients with Parkinson's disease. The findings may help to understand the psychosocial maladjustment and poor improvement in quality of life in some Parkinson's disease patients.
Collapse
Affiliation(s)
- Meyer Mylène
- Lorraine University, Metz 57000, France ; Department of Neurology, University Hospital, Nancy 54000, France ; INSERM, Clinical Investigation Center 9501, Vandoeuvre-les-Nancy 54500, France ; Department of Health Psychology EPSAM, EA 4360 APEMAC, Metz 57000, France
| | - Montel Sébastien
- Lorraine University, Metz 57000, France ; Department of Health Psychology EPSAM, EA 4360 APEMAC, Metz 57000, France
| | | | | | | | | | | | - Vespignani Hervé
- Lorraine University, Metz 57000, France ; Department of Neurology, University Hospital, Nancy 54000, France
| | - Barroche Gérard
- Department of Neurology, University Hospital, Nancy 54000, France
| | - Spitz Elisabeth
- Lorraine University, Metz 57000, France ; Department of Health Psychology EPSAM, EA 4360 APEMAC, Metz 57000, France
| | - Schwan Raymund
- Lorraine University, Metz 57000, France ; INSERM, Clinical Investigation Center 9501, Vandoeuvre-les-Nancy 54500, France ; Care, Support and Prevention Center in Addiction, University Hospital, Nancy 54000, France
| |
Collapse
|